Neumora plans clinical trials, data readouts through 2026
Go back to Neumora plans clinical trials, data readouts through 2026| (NASDAQ: NMRA) | Delayed: 0.39 +0.01 (2.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.38 | 52 Week High | $ | |||
| Open | $0.39 | 52 Week Low | $ | |||
| Day High | $0.43 | P/E | N/A | |||
| Day Low | $0.37 | EPS | $ | |||
| Volume | 512,157 | |||||



